Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties

Elisabeth Christiansen, Christian Urban, Manuel Grundmann, Maria E. Due-Hansen, Ellen Hagesaether, Johannes Schmidt, Leonardo Pardo, Susanne Ullrich, Evi Kostenis, Matthias Kassack, Trond Ulven

Research output: Contribution to journalArticleResearchpeer-review

58 Citations (Scopus)

Abstract

The free fatty acid receptor 1 (FFA1, also known as GPR40) enhances glucose-stimulated insulin secretion from pancreatic β-cells and is recognized as an interesting new target for treatment of type 2 diabetes. Several series of selective FFA1 agonists are already known. Most of these are derived from free fatty acids (FFAs) or glitazones and are relatively lipophilic. Aiming for the development of potent, selective, and less lipophilic FFA1 agonists, the terminal phenyl of a known compound series was replaced by nitrogen containing heterocycles. This resulted in the identification of 37, a selective FFA1 agonist with potent activity on recombinant human FFA1 receptors and on the rat insulinoma cell line INS-1E, optimal lipophilicity, and excellent in vitro permeability and metabolic stability. © 2011 American Chemical Society.
Original languageEnglish
Pages (from-to)6691-6703
JournalJournal of Medicinal Chemistry
Volume54
Issue number19
DOIs
Publication statusPublished - 13 Oct 2011

Fingerprint Dive into the research topics of 'Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties'. Together they form a unique fingerprint.

Cite this